What test should be ordered for a patient with prolonged diarrhea and potential recent antibiotic use or healthcare exposure to diagnose C. diff?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

C. difficile Testing Order

Order a single diarrheal stool specimen for C. difficile testing using either nucleic acid amplification testing (NAAT) or a two-step algorithm (GDH antigen screening followed by toxin detection). 1

Specimen Requirements

  • Collect one diarrheal stool sample that takes the shape of the container—this is the optimal specimen type 1
  • Fresh stool is preferred for C. difficile toxin detection 1
  • Do not order multiple specimens—repeat testing does not increase diagnostic yield and is not cost-effective 1, 2, 3

Recommended Testing Methods

The 2017 IDSA guidelines specify acceptable diagnostic approaches: 1

  • NAAT (nucleic acid amplification testing) for toxigenic C. difficile strain detection
  • Two-step algorithm: GDH antigen with or without toxin detection, followed by cytotoxin assay if needed
  • Direct toxin detection alone is not recommended due to insufficient sensitivity 4, 3

The two-step approach (GDH screening followed by toxin confirmation, or NAAT followed by toxin confirmation) balances sensitivity and specificity while avoiding false positives from asymptomatic colonization. 4

When to Order Testing

Test only when specific criteria are met: 1

  • Patients >2 years of age with diarrhea following antimicrobial use within the preceding 8-12 weeks
  • Healthcare-associated diarrhea (symptoms developing >72 hours after hospital admission) 1, 4
  • Persistent diarrhea without identified etiology even without recognized risk factors (weaker indication) 1

Critical Testing Restrictions

Do not test asymptomatic patients—asymptomatic colonization is common in hospitalized patients and long-term care residents, and testing without diarrhea leads to false-positive results that do not require treatment. 1, 5

Avoid testing in children <2 years of age unless other causes of diarrhea have been excluded, as asymptomatic colonization rates reach up to 70% in this age group. 6 By age 2-3 years, colonization rates fall to adult levels of 1-3%. 6

Common Pitfalls

  • Never order repeat testing after an initial negative result—the sensitivity of a single properly collected specimen is adequate, and multiple specimens do not improve detection 1, 2
  • Only test patients with active diarrhea (≥3 unformed stools in 24 hours)—testing formed stool or asymptomatic patients leads to detection of colonization rather than infection 4, 5
  • Do not order "test of cure" after treatment—post-treatment testing in asymptomatic patients is not recommended 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

C. difficile Infection Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clostridium difficile-associated diarrhea and colitis.

Infection control and hospital epidemiology, 1995

Guideline

Treatment for C. difficile Infection in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.